Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2019 | Next steps for CAR-T in ALL

Stephan Grupp • 7 Dec 2019
ASH 2019
Acute Lymphoblastic Leukemia Leukemia CAR-T

Stephan Grupp, MD, PhD, Children’s Hospital of Philadelphia, Philadelphia, PA, shares his opinion on what should now be the focus of CAR-T research in acute lymphoblastic leukemia (ALL). Dr Grupp highlights the need for longer follow-ups, extending the reach of CAR-T therapies, and improvements in manufacturing. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

More from Stephan Grupp

Patient selection for CAR-T in ALL
1:33
Patient selection for CAR-T in ALL
Stephan Grupp • 2 Sep 2021
The latest research in ALL cellular therapy
2:16
The latest research in ALL cellular therapy
Stephan Grupp • 2 Sep 2021
The future of treating pediatric ALL with CAR-T
1:21
The future of treating pediatric ALL with CAR-T
Stephan Grupp • 2 Sep 2021
The importance of common language for CAR-T
0:57
The importance of common language for CAR-T
Stephan Grupp • 18 Mar 2021

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals